Eva-Maria Strauch

Prof. Dr. Eva-Maria Strauch

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Science
Verified
Journal Article
Open access
PDF file
LCLongxing Cao
Longxing Cao
IGInna Goreshnik
Inna Goreshnik
BCBrian Coventry
Brian Coventry
JCJames Brett Case
James Brett Case
LMLauren Miller
Lauren Miller
DBDavid Baker
David Baker
Miniproteins against SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is decorated with spikes, and viral entry into cells is initiated when these spikes bind to the host angiotensin-converting enzyme 2 (ACE2) receptor. Many monoclonal antibody therapies in development target the spike proteins. Cao et al. designed small, stable proteins that bind tightly to the spike and block it from binding to ACE2. The best designs bind with very high affinity and prevent SARS-CoV-2 infection of mammalian Vero E6 cells. Cryo–electron microscopy shows that the structures of the two most potent inhibitors are nearly identical to the computational models. Unlike antibodies, the miniproteins do not require expression in mammalian cells, and their small size and high stability may allow formulation for direct delivery to the nasal or respiratory system. Science , this issue p. 426

24 March 2022 in Nature
Verified
Journal Article
Open access
PDF file
LCLongxing Cao
Longxing Cao
BCBrian Coventry
Brian Coventry
IGInna Goreshnik
Inna Goreshnik
BHBuwei Huang
Buwei Huang
WSWilliam Sheffler
William Sheffler
DBDavid Baker
David Baker
The design of proteins that bind to a specific site on the surface of a target protein using no information other than the three-dimensional structure of the target remains a challenge1–5. Here we describe a general solution to this problem that starts with a broad exploration of the vast space of possible binding modes to a selected region of a protein surface, and then intensifies the search in the vicinity of the most promising binding modes. We demonstrate the broad applicability of this approach through the de novo design of binding proteins to 12 diverse protein targets with different shapes and surface properties. Biophysical characterization shows that the binders, which are all smaller than 65 amino acids, are hyperstable and, following experimental optimization, bind their targets with nanomolar to picomolar affinities. We succeeded in solving crystal structures of five of the binder–target complexes, and all five closely match the corresponding computational design models. Experimental data on nearly half a million computational designs and hundreds of thousands of point mutants provide detailed feedback on the strengths and limitations of the method and of our current understanding of protein–protein interactions, and should guide improvements of both. Our approach enables the targeted design of binders to sites of interest on a wide variety of proteins for therapeutic and diagnostic applications.

15 November 2022 in Bioinformatics
Verified
Journal Article
Open access
PDF file
RSRaulia Syrlybaeva
Raulia Syrlybaeva
ESEva-Maria Strauch
Eva-Maria Strauch
As more data of experimentally determined protein structures are becoming available, data-driven models to describe protein sequence–structure relationships become more feasible. Within this space, the amino acid sequence design of protein–protein interactions is still a rather challenging subproblem with very low success rates—yet, it is central to most biological processes. We developed an attention-based deep learning model inspired by algorithms used for image-caption assignments to design peptides or protein fragment sequences. Our trained model can be applied for the redesign of natural protein interfaces or the designed protein interaction fragments. Here, we validate the potential by recapitulating naturally occurring protein–protein interactions including antibody–antigen complexes. The designed interfaces accurately capture essential native interactions and have comparable native-like binding affinities in silico. Furthermore, our model does not need a precise backbone location, making it an attractive tool for working with de novo design of protein–protein interactions. The source code of the method is available at https://github.com/strauchlab/iNNterfaceDesign Supplementary data are available at Bioinformatics online.

22 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
TLThomas W. Linsky
Thomas W. Linsky
KNKyle Noble
Kyle Noble
ATAutumn R. Tobin
Autumn R. Tobin
RCRachel Crow
Rachel Crow
LCLauren Carter
Lauren Carter
ESEva-Maria Strauch
Eva-Maria Strauch
Nature only samples a small fraction of the sequence space that can fold into stable proteins. Furthermore, small structural variations in a single fold, sometimes only a few amino acids, can define a protein’s molecular function. Hence, to design proteins with novel functionalities, such as molecular recognition, methods to control and sample shape diversity are necessary. To explore this space, we developed and experimentally validated a computational platform that can design a wide variety of small protein folds while sampling shape diversity. We designed and evaluated stability of about 30,000 de novo protein designs of eight different folds. Among these designs, about 6,200 stable proteins were identified, including some predicted to have a first-of-its-kind minimalized thioredoxin fold. Obtained data revealed protein folding rules for structural features such as helix-connecting loops. Beyond serving as a resource for protein engineering, this massive and diverse dataset also provides training data for machine learning. We developed an accurate classifier to predict the stability of our designed proteins. The methods and the wide range of protein shapes provide a basis for designing new protein functions without compromising stability.

13 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KGKaren Juliana Gonzalez
Karen Juliana Gonzalez
JHJiachen Huang
Jiachen Huang
MCMiria F. Criado
Miria F. Criado
ABAvik Banerjee
Avik Banerjee
Stephen Mark TompkinsStephen Mark Tompkins
Stephen Mark Tompkins
ESEva-Maria Strauch
Eva-Maria Strauch
Many pathogenic viruses rely on class I fusion proteins to fuse their viral membrane with the host cell membrane. To drive the fusion process, class I fusion proteins undergo an irreversible conformational change from a metastable prefusion state to an energetically more stable postfusion state. Mounting evidence underscores that antibodies targeting the prefusion conformation are the most potent, making it a compelling vaccine candidate. Here, we establish a computational design protocol that stabilizes the prefusion state while destabilizing the postfusion conformation. With this protocol, we stabilize the fusion proteins of the RSV, hMPV, and SARS-CoV-2 viruses, testing fewer than a handful of designs. The solved structures of these designed proteins from all three viruses evidence the atomic accuracy of our approach. Furthermore, the humoral response of the redesigned RSV F protein compares to that of the recently approved vaccine in a mouse model. While the parallel design of two conformations allows the identification of energetically sub-optimal positions for one conformation, our protocol also reveals diverse molecular strategies for stabilization. Given the clinical significance of viruses using class I fusion proteins, our algorithm can substantially contribute to vaccine development by reducing the time and resources needed to optimize these immunogens.

13 April 2020 in Biochemistry
Verified
Journal Article
Closed access
HKHyun W. Kim
Hyun W. Kim
AEAlexander Eletsky
Alexander Eletsky
KGKaren Juliana Gonzalez
Karen Juliana Gonzalez
HWHanke van der Wel
Hanke van der Wel
ESEva-Maria Strauch
Eva-Maria Strauch
CWChristopher Mark West
Christopher Mark West